PepGen Inc.(PEPG)
Biotechnology
Rare Disease / Orphan Drug
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | Kasraian Kasra Chief Technical Officer | Sale | -1,233 | -6.58%17,517 | $1.41 | $1,739 | View SEC filing | |
| 2026-03-06 | STRECK PAUL EVP, Head of R&D | Sale | -1,879 | -2.41%76,226 | $6.23 | $11,709 | View SEC filing | |
| 2026-03-06 | Donnelly Noel Chief Financial Officer | Sale | -2,084 | -1.83%111,603 | $6.23 | $12,988 | View SEC filing | |
| 2026-03-06 | McArthur James G President and CEO | Sale | -5,275 | -1.75%296,326 | $6.23 | $32,876 | View SEC filing | |
| 2025-10-01 | Oxford Science Enterprises plc Other | Purchase | +200,000 | +4.21%4,955,388 | $3.20 | $640,000 | View SEC filing | |
| 2025-09-30 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +9,375,000 | +102.13%18,554,273 | $3.20 | $30,000,000 | View SEC filing | |
| 2025-06-02 | STRECK PAUL EVP, Head of R&D | Purchase | +8,375 | +43.10%27,805 | $1.24 | $10,393 | View SEC filing | |
| 2025-04-22 | McArthur James G President and CEO | Purchase | +10,000 | +9.62%113,913 | $1.35 | $13,550 | View SEC filing | |
| 2025-04-09 | McArthur James G President and CEO | Purchase | +41,500 | +66.49%103,913 | $1.15 | $47,725 | View SEC filing | |
| 2025-02-26 | DeLena Mary Beth General Counsel | Sale | -1,432 | -47.73%1,568 | $1.68 | $2,406 | View SEC filing | |
| 2025-02-26 | Donnelly Noel Chief Financial Officer | Sale | -1,527 | -47.72%1,673 | $1.68 | $2,565 | View SEC filing | |
| 2024-07-26 | Mellion Michelle L Chief Medical Officer | Sale | -7,772 | -100.00%0 | $18.06 | $140,360 | View SEC filing | |
| 2024-07-19 | Mellion Michelle L Chief Medical Officer | Sale | -12,625 | -100.00%0 | $18.20 | $229,804 | View SEC filing | |
| 2024-07-16 | Mellion Michelle L Chief Medical Officer | Sale | -9,189 | -100.00%0 | $18.02 | $165,578 | View SEC filing | |
| 2024-07-03 | Mellion Michelle L Chief Medical Officer | Sale | -912 | -100.00%0 | $18.01 | $16,428 | View SEC filing | |
| 2024-06-26 | Mellion Michelle L Chief Medical Officer | Sale | -9,260 | -100.00%0 | $18.19 | $168,427 | View SEC filing | |
| 2024-06-13 | Mellion Michelle L Chief Medical Officer | Sale | -1,586 | -100.00%0 | $18.06 | $28,637 | View SEC filing | |
| 2024-06-07 | Mellion Michelle L SVP, Clinical Development | Sale | -8,656 | -100.00%0 | $18.08 | $156,460 | View SEC filing | |
| 2024-05-17 | Svenstrup Niels SVP, Chem. Mfg & Controls | Sale | -10,000 | -100.00%0 | $13.41 | $134,100 | View SEC filing | |
| 2024-04-09 | Oxford Science Enterprises plc 10% Owner | Purchase | +879,970 | +22.71%4,755,388 | $12.00 | $10,559,640 | View SEC filing | |
| 2024-02-13 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +2,557,593 | +38.62%9,179,273 | $10.64 | $27,212,790 | View SEC filing | |
| 2023-12-05 | McArthur James G President and CEO | Purchase | +1,694 | +100.00%1,694 | $4.17 | $7,056 | View SEC filing | |
| 2023-06-09 | McArthur James G President and CEO | Sale | -2,381 | -100.00%0 | $16.04 | $38,188 | View SEC filing | |
| 2023-06-08 | McArthur James G President and CEO | Sale | -26,569 | -100.00%0 | $16.19 | $430,277 | View SEC filing | |
| 2023-06-06 | McArthur James G President and CEO | Sale | -2,300 | -100.00%0 | $16.04 | $36,891 | View SEC filing |
1-25 of 30
Page 1 of 2